2020 annual financial data
BridgeBio Pharma 2020 Operating margin
BridgeBio Pharma 2020 operating margin with verified reported values.
Direct answer
Operating margin was -5,751.99%.
Operating income was -474,482,000 USD and net income was -448,724,000 USD.
Operating cash flow was -399,714,000 USD.
Verified data
- Revenue
- 8,249,000 USD
- Operating income
- -474,482,000 USD
- Net income
- -448,724,000 USD
- Operating cash flow
- -399,714,000 USD